These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend. Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418 [TBL] [Abstract][Full Text] [Related]
4. Control of Gramatniece A; Silamikelis I; Zahare I; Urtans V; Zahare I; Dimina E; Saule M; Balode A; Radovica-Spalvina I; Klovins J; Fridmanis D; Dumpis U Antimicrob Resist Infect Control; 2019; 8():84. PubMed ID: 31143444 [TBL] [Abstract][Full Text] [Related]
5. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa. Founou RC; Founou LL; Allam M; Ismail A; Essack SY Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant Douraghi M; Kenyon JJ; Aris P; Asadian M; Ghourchian S; Hamidian M mSphere; 2020 Apr; 5(2):. PubMed ID: 32269158 [TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit. Karampatakis T; Tsergouli K; Politi L; Diamantopoulou G; Iosifidis E; Antachopoulos C; Karyoti A; Mouloudi E; Tsakris A; Roilides E Microb Drug Resist; 2019 Jun; 25(5):712-716. PubMed ID: 30589601 [TBL] [Abstract][Full Text] [Related]
8. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs. Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444 [TBL] [Abstract][Full Text] [Related]
9. Emergence of multiple carbapenemase-producing Gram-negative species, colistin-resistant KPC-2-producing Klebsiella pneumoniae ST11, IMP-7-producing Pseudomonas aeruginosa ST357, and OXA-23-producing Acinetobacter baumannii ST1050, in a single patient. Nishida S; Ishigaki S; Asahara M; Furukawa T; Ono Y Int J Antimicrob Agents; 2018 Oct; 52(4):512-514. PubMed ID: 30318057 [No Abstract] [Full Text] [Related]
11. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232 [TBL] [Abstract][Full Text] [Related]
12. Outbreak of KPC-2-Producing Su S; Li C; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Zhang J; Zhang X Microb Drug Resist; 2020 Sep; 26(9):1009-1018. PubMed ID: 32150494 [No Abstract] [Full Text] [Related]
13. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care. Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971 [TBL] [Abstract][Full Text] [Related]
14. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit. Maina JW; Mutua JM; Musyoki AM BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175 [TBL] [Abstract][Full Text] [Related]
15. Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA). Rao J; Susanti D; Childress JC; Mitkos MC; Brima JK; Baffoe-Bonnie AW; Pearce SN; Grgurich D; Fernandez-Cotarelo MJ; Kerkering TM; Mukhopadhyay B J Glob Antimicrob Resist; 2018 Mar; 12():79-87. PubMed ID: 28899807 [TBL] [Abstract][Full Text] [Related]
16. Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs. Hammerum AM; Hansen F; Skov MN; Stegger M; Andersen PS; Holm A; Jakobsen L; Justesen US J Antimicrob Chemother; 2015 Jul; 70(7):1965-8. PubMed ID: 25795772 [TBL] [Abstract][Full Text] [Related]
17. Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China. Li J; Yu T; Luo Y; Peng JY; Li YJ; Tao XY; Hu YM; Wang HC; Zou MX BMC Microbiol; 2020 Sep; 20(1):281. PubMed ID: 32928115 [TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit. Munier AL; Biard L; Rousseau C; Legrand M; Lafaurie M; Lomont A; Donay JL; de Beaugrenier E; Flicoteaux R; Mebazaa A; Mimoun M; Molina JM J Hosp Infect; 2017 Nov; 97(3):226-233. PubMed ID: 28751010 [TBL] [Abstract][Full Text] [Related]
19. Outbreak of a cluster with epidemic behavior due to Serratia marcescens after colistin administration in a hospital setting. Merkier AK; Rodríguez MC; Togneri A; Brengi S; Osuna C; Pichel M; Cassini MH; ; Centrón D J Clin Microbiol; 2013 Jul; 51(7):2295-302. PubMed ID: 23698525 [TBL] [Abstract][Full Text] [Related]
20. Whole genome sequence revealed the fine transmission map of carbapenem-resistant Sui W; Zhou H; Du P; Wang L; Qin T; Wang M; Ren H; Huang Y; Hou J; Chen C; Lu X Antimicrob Resist Infect Control; 2018; 7():70. PubMed ID: 29881543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]